BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

SFL's Managing Director to Give Presentation at Informa's 8th Annual Drug Device Combination Products Event in Berlin


11/11/2013 9:56:39 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

November 11, 2013 -- SFL is pleased to announce that Shayesteh Fürst-Ladani, Managing Director of the company, will be giving a presentation at Informa’s 8th Annual Drug Device Combination Products event, which will be held on 19-20 November in Berlin. The event will cover regulatory updates, real life examples and strategic advice for successful approval of device-drug and drug-device combination products globally. During the afternoon session on Wednesday 20 November, Ms. Fürst-Ladani will give a presentation entitled “Overview of current and future clinical data requirements for combination products.”

In her wide-ranging presentation, she will outline the clinical strategies suitable to support combination products applications, examine the current requirements and discuss proposed changes in the revision of the Medical Devices Directives.

“The classification of a product has a huge impact on its clinical development, the regulatory pathway, costs and timelines for companies,” she remarked.

“Since different rules apply for clinical investigations regarding drug and device combinations, it is imperative that companies apply the appropriate strategy and seek expert advice.”

Ms. Fürst-Ladani is the Managing Director and founder of SFL. She has comprehensive experience in formulating global regulatory strategies and provides support for the development of drugs, orphan drugs, drug and device combination products, borderline products, medical devices, in vitro diagnostics and advanced therapy medicinal products. She is Chair of the Combination Products Topic Group at EuropaBio. She has been member of the Program Committee of DIA EuroMeetings 2011, 2012, 2013 and 2014 leading the Theme Drugs, Devices, In Vitro Diagnostics and their Combinations. In 2012, she received the Open University Business School’s Alumni Award Outstanding “Contribution to an Organization”.

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES